AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35331718 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS + exercising
Number of subjects: 120
Study 35331718 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham tDCS + exercising
Number of subjects: 120
Study 35331718 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 120
Study 33278181 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring (VR)
Number of subjects: 60
Study 35685671 — intervention group
Group type: EXPERIMENTAL
Intervention: CVVH combined with Xuebijing
Number of subjects: 100
Study 33523488 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-family holistic care intervention based on 'Timing It Right'
Number of subjects: 125
Study 33523488 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine care and follow-up)
Number of subjects: 125
Study 32796901 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized T7 promoter (CEL-Seq+)
Number of subjects: 0
Study 32796901 — intervention group
Group type: EXPERIMENTAL
Intervention: T7 promoter variants with enhanced transcriptional output
Number of subjects: 0
Study 32796901 — intervention group
Group type: COMPARATOR
Intervention: Standard T7 promoter (implied control)
Number of subjects: 0
Study 35390339 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 202
Study 35390339 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab-ipilimumab
Number of subjects: 202
Study 35390339 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGFR-TKI
Number of subjects: 202
Study 35390339 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 202
Study 33608711 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 119
Study 33608711 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 35627740 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking (aerobic exercise)
Number of subjects: 88
Study 35627740 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance (dual-task training with aerobic exercise)
Number of subjects: 88
Study 35627740 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 88
Study 35002970 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin 5 mg PO daily throughout hospitalization
Number of subjects: 64
Study 35002970 — intervention group
Group type: COMPARATOR
Intervention: Standard of care therapy
Number of subjects: 64
Study 35662590 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy score (mean 3.01, SD = 0.49)
Number of subjects: 1078
Study 32975391 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise training (CBT)
Number of subjects: 20
Study 32975391 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 20
Study 32249034 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART intervention
Number of subjects: 105
Study 32249034 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WL)
Number of subjects: 105
Study 35474759 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Help Plus (SH+) intervention for 1 month
Number of subjects: 0
Study 35474759 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving information about mental health promotion
Number of subjects: 0
Study 33862565 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 50
Study 33862565 — intervention group
Group type: COMPARATOR
Intervention: Nasopore (Control)
Number of subjects: 50
Study 35608826 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing a surgical mask (MASK) during HIIE
Number of subjects: 10
Study 35608826 — intervention group
Group type: COMPARATOR
Intervention: Not wearing a surgical mask (CON) during HIIE
Number of subjects: 10
Study 32696695 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Monitoring of Blood Pressure (SMBP) with feedback to patient or provider
Number of subjects: 2590
Study 32696695 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Monitoring of Blood Pressure (SMBP) with telemonitoring or self-management
Number of subjects: 2590
Study 32696695 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2590
Study 32696695 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended SMBP interventions for 5 years
Number of subjects: 2590
Study 32696695 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended SMBP with telemonitoring or self-management for 5 years
Number of subjects: 2590
Study 36242089 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-PEMF
Number of subjects: 118
Study 36242089 — intervention group
Group type: COMPARATOR
Intervention: Inactive control (placebo)
Number of subjects: 118
Study 35224710 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 µg/day)
Number of subjects: 60
Study 34333803 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg once daily
Number of subjects: 60
Study 34333803 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 50 mg twice daily
Number of subjects: 60
Study 34333803 — intervention group
Group type: COMPARATOR
Intervention: Metformin 1 g twice daily
Number of subjects: 60
Study 33713359 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib
Number of subjects: 0
Study 33713359 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib in combination with aromatase inhibitors or fulvestrant
Number of subjects: 0
Study 32334615 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonke CHANGE intervention delivered over 18 months, including community action activities such as door-to-door discussions and workshops.
Number of subjects: 2406
Study 32334615 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonke CHANGE intervention delivered over 18 months.
Number of subjects: 2406
Study 35835944 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-based intervention
Number of subjects: 54
Study 35835944 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 54
Study 35835944 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 54
Study 33185897 — intervention group
Group type: EXPERIMENTAL
Intervention: RT+AT (Resistance Training + Aerobic Training)
Number of subjects: 40
Study 32219762 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation over 12 weeks
Number of subjects: 0
Study 32219762 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36000718 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine (20 mg)
Number of subjects: 43
Study 36000718 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 43
Study 35766559 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT-milk
Number of subjects: 45
Study 35766559 — intervention group
Group type: COMPARATOR
Intervention: Placebo milk
Number of subjects: 45
Study 32124732 — intervention group
Group type: EXPERIMENTAL
Intervention: GeoPain measures
Number of subjects: 125
Study 32124732 — intervention group
Group type: COMPARATOR
Intervention: Visual Analog Scale (VAS)
Number of subjects: 125
Study 32124732 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Area and Intensity Number Summation (PAINS)
Number of subjects: 125
Study 32124732 — intervention group
Group type: EXPERIMENTAL
Intervention: PAINS
Number of subjects: 125
Study 32124732 — intervention group
Group type: COMPARATOR
Intervention: VAS
Number of subjects: 125
Study 34383958 — intervention group
Group type: EXPERIMENTAL
Intervention: Ekso training
Number of subjects: 6
Study 34383958 — intervention group
Group type: COMPARATOR
Intervention: Lokomat training
Number of subjects: 6
Study 32956867 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 ppm Pb in drinking water for 36 days
Number of subjects: 4
Study 32956867 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 ppm Pb in drinking water for 36 days
Number of subjects: 4
Study 32956867 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 ppm Pb in drinking water for 36 days
Number of subjects: 4
Study 32956867 — intervention group
Group type: COMPARATOR
Intervention: 0 ppm Pb in drinking water for 36 days
Number of subjects: 4
Study 35995105 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week tailored text message smoking-cessation program with a companion web-based intervention (n = 172)
Number of subjects: 343
Study 35995105 — intervention group
Group type: COMPARATOR
Intervention: Referral to online quit resources (usual care control; n = 171)
Number of subjects: 343
Study 33407612 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (TRF)
Number of subjects: 20
Study 33407612 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=12, BMI 34.55 ± 1.20)
Number of subjects: 20
Study 35152509 — intervention group
Group type: EXPERIMENTAL
Intervention: OneShape rotary system (Micro‐Mega)
Number of subjects: 164
Study 35152509 — intervention group
Group type: COMPARATOR
Intervention: WaveOne Gold reciprocating system (Dentsply Maillefer)
Number of subjects: 164
Study 34717750 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Intervention Therapy (VIT)
Number of subjects: 30
Study 34717750 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study 32993116 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradually Reduced Nicotine Content (RNC) group
Number of subjects: 0
Study 32993116 — intervention group
Group type: COMPARATOR
Intervention: Usual Nicotine Content (UNC) group
Number of subjects: 0
Study 35089964 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringers lactate (RL)
Number of subjects: 51
Study 35089964 — intervention group
Group type: COMPARATOR
Intervention: Normal Saline (NS)
Number of subjects: 51
Study 33449309 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity resistance training (HIRT)
Number of subjects: 43
Study 33449309 — intervention group
Group type: COMPARATOR
Intervention: Control group (inactive)
Number of subjects: 43
Study 33858965 — intervention group
Group type: EXPERIMENTAL
Intervention: Industry‐proposed disclaimer
Number of subjects: 807
Study 33858965 — intervention group
Group type: EXPERIMENTAL
Intervention: Moonlight ads
Number of subjects: 807
Study 32596783 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1/oxaliplatin (SOX)
Number of subjects: 338
Study 32596783 — intervention group
Group type: COMPARATOR
Intervention: S-1/cisplatin (SP3)
Number of subjects: 338
Study 32971053 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based ART delivery
Number of subjects: 1315
Study 32971053 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid approach (clinic initiation + mobile van monitoring)
Number of subjects: 1315
Study 32971053 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based ART delivery among men
Number of subjects: 1315
Study 32971053 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid approach among men
Number of subjects: 1315
Study 32971053 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based ART
Number of subjects: 1315
Study 35564808 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen-rich water (HRW)
Number of subjects: 18
Study 35564808 — intervention group
Group type: COMPARATOR
Intervention: Placebo water (PW)
Number of subjects: 18
Study 34161146 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed (40-g packets daily before and during radiotherapy)
Number of subjects: 33
Study 33052401 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab-axitinib
Number of subjects: 100000
Study 33052401 — intervention group
Group type: COMPARATOR
Intervention: Nivolumab-ipilimumab
Number of subjects: 100000
Study 33766835 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 430
Study 33766835 — intervention group
Group type: COMPARATOR
Intervention: Observation/conservative management (medical management)
Number of subjects: 430
Study 32012190 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2R1/rs10741657 heterozygote carriage
Number of subjects: 920
Study 32012190 — intervention group
Group type: EXPERIMENTAL
Intervention: GC/rs4588 heterozygote carriage
Number of subjects: 920
Study 32012190 — intervention group
Group type: EXPERIMENTAL
Intervention: Carriage of two risk alleles (genetic risk score)
Number of subjects: 920
Study 35232217 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening with handheld single-lead ECG (AliveCor KardiaMobile) during vital sign assessments.
Number of subjects: 30715
Study 35232217 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 30715
Study 34255703 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone-based life-skills training program (SmartCoach) over 22 weeks
Number of subjects: 1473
Study 32340248 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal Fat Oxidation (BFox)
Number of subjects: 71
Study 32340248 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal Carbohydrate Oxidation (BCHox)
Number of subjects: 71
Study 32340248 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal Metabolic Rate (BMR)
Number of subjects: 71
Study 35385425 — intervention group
Group type: EXPERIMENTAL
Intervention: VGH-BPH1
Number of subjects: 0
Study 35385425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34499583 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular/oculomotor rehabilitation protocol
Number of subjects: 27
Study 32431299 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle interventions
Number of subjects: 100
Study 34478532 — intervention group
Group type: EXPERIMENTAL
Intervention: BST-Cargel after arthroscopic microfracture
Number of subjects: 62
Study 34478532 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP after arthroscopic microfracture
Number of subjects: 62
Study 34478532 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic microfracture (MF)
Number of subjects: 62
Study 35835755 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir (TFV) intravaginal ring
Number of subjects: 27
Study 35835755 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir and levonorgestrel (TFV/LNG) intravaginal ring
Number of subjects: 27
Study 35835755 — intervention group
Group type: COMPARATOR
Intervention: Placebo intravaginal ring
Number of subjects: 27
Study 34145796 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants
Number of subjects: 0
Study 34145796 — intervention group
Group type: COMPARATOR
Intervention: Noneligible patients
Number of subjects: 0
Study 34145796 — intervention group
Group type: COMPARATOR
Intervention: Nonconsenting patients
Number of subjects: 0
Study 34699278 — intervention group
Group type: EXPERIMENTAL
Intervention: Head and neck melanoma (HNM)
Number of subjects: 39754
Study 34699278 — intervention group
Group type: EXPERIMENTAL
Intervention: Melanoma of the scalp and neck (MSN)
Number of subjects: 39754
Study 32499244 — intervention group
Group type: EXPERIMENTAL
Intervention: CRD (cyclophosphamide, lenalidomide, and dexamethasone)
Number of subjects: 2042
Study 32499244 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide maintenance
Number of subjects: 2042
Study 32499244 — intervention group
Group type: COMPARATOR
Intervention: CTD (cyclophosphamide, thalidomide, and dexamethasone)
Number of subjects: 2042
Study 32499244 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 2042
Study 32291974 — intervention group
Group type: EXPERIMENTAL
Intervention: Full endoscopic transforaminal decompression (FETD) under local anesthesia
Number of subjects: 63
Study 36104059 — intervention group
Group type: EXPERIMENTAL
Intervention: ESPB (Erector Spinae Plane Block) with 20 mL of 0.25% bupivacaine
Number of subjects: 30
Study 36104059 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ESPB)
Number of subjects: 30
Study 36104059 — intervention group
Group type: EXPERIMENTAL
Intervention: ESPB
Number of subjects: 30
Study 32619238 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigator-initiated trials
Number of subjects: 0
Study 32619238 — intervention group
Group type: COMPARATOR
Intervention: Industry-led trials
Number of subjects: 0
Study 32578800 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric Toothbrush (ET)
Number of subjects: 29
Study 32578800 — intervention group
Group type: COMPARATOR
Intervention: Manual Toothbrush (MT)
Number of subjects: 29
Study 32578800 — intervention group
Group type: EXPERIMENTAL
Intervention: Both toothbrush types
Number of subjects: 29
Study 35712521 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanyin formula (SYF) plus conventional standard chemotherapy
Number of subjects: 252
Study 35712521 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus conventional standard chemotherapy
Number of subjects: 252
Study 34404628 — intervention group
Group type: EXPERIMENTAL
Intervention: Training session for primary care workers based on the Brazilian National Guidelines for Children
Number of subjects: 715
Study 36074816 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-arm-assisted TKA
Number of subjects: 30
Study 36074816 — intervention group
Group type: COMPARATOR
Intervention: Conventional jig-based TKA
Number of subjects: 30
Study 32460116 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group exercise (60 min, 2 times/week)
Number of subjects: 90
Study 32460116 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 90
Study 35838186 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-fluidics system (AFS)
Number of subjects: 107
Study 35838186 — intervention group
Group type: COMPARATOR
Intervention: Gravity-fluidics system (GFS)
Number of subjects: 107
Study 34606560 — intervention group
Group type: EXPERIMENTAL
Intervention: Borage oil (880 mg GLA per day)
Number of subjects: 0
Study 34606560 — intervention group
Group type: COMPARATOR
Intervention: Evening primrose oil (540 mg GLA per day)
Number of subjects: 0
Study 36353999 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 4071
Study 36353999 — intervention group
Group type: COMPARATOR
Intervention: Control (discontinue all antihypertensive medications)
Number of subjects: 4071
Study 33987915 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model
Number of subjects: 162
Study 33987915 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical‐laboratory model
Number of subjects: 162
Study 33987915 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics‐clinical‐laboratory model
Number of subjects: 162
Study 33987915 — intervention group
Group type: EXPERIMENTAL
Intervention: Multipredictor nomogram
Number of subjects: 162
Study 32838673 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure reduction (goal 110‐139 mm Hg)
Number of subjects: 1000
Study 32838673 — intervention group
Group type: COMPARATOR
Intervention: Standard systolic blood pressure reduction (goal 140‐179 mm Hg)
Number of subjects: 1000
Study 35438442 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth Cognitive-Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 30
Study 35438442 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 30
Study 33439215 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic risk score (PRS) for depression
Number of subjects: 17098
Study 33439215 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental history of mood or psychotic disorders
Number of subjects: 17098
Study 33439215 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower socioeconomic status (SES)
Number of subjects: 17098
Study 33439215 — intervention group
Group type: COMPARATOR
Intervention: Combination of risk factors (high SES, low PRS)
Number of subjects: 17098
Study 33439215 — intervention group
Group type: COMPARATOR
Intervention: Combination of risk factors (high PRS, parental history)
Number of subjects: 17098
Study 32699176 — intervention group
Group type: EXPERIMENTAL
Intervention: NEWSUP (new food supplement, high in plant polyphenols and omega 3 fatty acids, fortified with micronutrients, high protein content)
Number of subjects: 1059
Study 32699176 — intervention group
Group type: EXPERIMENTAL
Intervention: NEWSUP
Number of subjects: 1059
Study 36078788 — intervention group
Group type: EXPERIMENTAL
Intervention: PEFLOW (Pelvic Floor Workout) performed online under the supervision of a physiotherapist for 12 weeks
Number of subjects: 260
Study 36078788 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control Group)
Number of subjects: 260
Study 33567780 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirulina maxima intake (5 g/day)
Number of subjects: 52
Study 33567780 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 52
Study 33567780 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirulina maxima intake (5 g/day) + Exercise program
Number of subjects: 52
Study 33567780 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Spirulina or exercise)
Number of subjects: 52
Study 34941611 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO mouth rinse
Number of subjects: 12
Study 34941611 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study 35130898 — intervention group
Group type: EXPERIMENTAL
Intervention: selfBACK app (AI-based app for self-management support)
Number of subjects: 461
Study 34097526 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace wellness program including modules on nutrition, physical activity, and stress reduction, implemented by registered dietitians.
Number of subjects: 160
Study 34097526 — intervention group
Group type: COMPARATOR
Intervention: Control group (no workplace wellness program).
Number of subjects: 160
Study 33375174 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil + probiotics
Number of subjects: 0
Study 33375174 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics + placebo
Number of subjects: 0
Study 33375174 — intervention group
Group type: COMPARATOR
Intervention: Fish oil + placebo
Number of subjects: 0
Study 33786663 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomical position
Number of subjects: 24
Study 33786663 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk position (abducted and externally rotated arm position)
Number of subjects: 24
Study 33786663 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonunion
Number of subjects: 24
Study 33786663 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical outcomes (Constant, Rowe, Walch-Duplay scores)
Number of subjects: 24
Study 32725604 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbott iSTAT
Number of subjects: 186